AIPHARMA DEVELOPMENT LLC – Trademark Portfolio

Entity Type: 16

AIPHARMA DEVELOPMENT LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include QIFENDA. The owner is based in Dubai.

One JLT, 14th floor

Jumeirah Lake Towers

Dubai , AE

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PREPAIRE
PREPAIRE
Abandoned 2021
QIFENDA
QIFENDA
Registered 2021

Trademark Classifications

AIPHARMA DEVELOPMENT LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does AIPHARMA DEVELOPMENT LLC have?

AIPHARMA DEVELOPMENT LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does AIPHARMA DEVELOPMENT LLC file in?

AIPHARMA DEVELOPMENT LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are AIPHARMA DEVELOPMENT LLC's most well-known trademarks?

AIPHARMA DEVELOPMENT LLC's registered trademark portfolio includes well-known marks such as QIFENDA. These are among 1 currently registered trademark in the portfolio.

What is AIPHARMA DEVELOPMENT LLC's trademark registration success rate?

AIPHARMA DEVELOPMENT LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.